Autres langues ContraFect Corporation

Actions

CFRXQ

US2123264093

Recherche biotechnologique et médicale

Temps Différé OTC Markets Autres places de cotation 17:49:59 26/06/2026			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	-.--%		-.--%	-

05/12/23	ContraFect Corporation annonce la démission de ses dirigeants	CI
05/12/23	ContraFect Corporation annonce la démission de Michael Messinger en tant que directeur général	CI

Autres langues

09/02/24	Bidding Procedure Approved for ContraFect Corporation
12/01/24	Motion for Asset Sale Filed by ContraFect Corporation
05/12/23	ContraFect Corporation Announces Resignation of Michael Messinger as Chief Financial Officer
05/12/23	ContraFect Corporation Announces Management Resignations
05/12/23	ContraFect Corporation Announces Resignation of Michael Messinger as Chief Executive Officer
04/12/23	ContraFect Corporation Filed for Bankruptcy
15/11/23	ContraFect Corporation Announces Chief Executive Officer Changes
15/11/23	ContraFect Corporation Announces Executive Changes
15/11/23	ContraFect Corporation Appoints Michael Messinger as Chief Financial Officer
15/11/23	ContraFect Corporation Implements Restructuring Plan Resulting in Reduction to Workforce from A Total of 23 Employees to Five Employee
14/11/23	ContraFect: Q3 Earnings Snapshot
14/11/23	ContraFect Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
13/11/23	ContraFect Corporation(OTCPK:CFRX) dropped from S&P TMI Index
08/11/23	ContraFect Corporation(OTCPK:CFRX) dropped from NASDAQ Composite Index
16/10/23	ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study
19/09/23	ContraFect to Present at the ASM/ESCMID Joint Conference on Drug Development
18/09/23	ContraFect Submits Investigational New Drug Application for Bacterial Pneumonia Treatment
18/09/23	ContraFect Announces Submission of IND Application to the FDA for its Development Candidate CF-370
28/08/23	ContraFect to Present at the World Anti-Microbial Resistance Congress 2023
16/08/23	ContraFect : Q2 2023 Investor Presentation
14/08/23	ContraFect: Q2 Earnings Snapshot
14/08/23	ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update
14/08/23	ContraFect Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
27/06/23	ContraFect Enters Into a Warrant Exercise Transaction for Proceeds of $9.6 Million
23/06/23	ContraFect Corporation(NasdaqCM:CFRX) dropped from Russell Microcap Value Index